Skip to content

A clinical study to evaluate the efficacy of vranaropankar churna in the treatment of suddha vrana

Randomized controlled clinical trial to evaluate the ropan effect of vranaropankar churna local application in the management of shuddha vrana - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077292
Enrollment
70
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr.Umesh Abhiman Paikrao
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having vrana in shudha awastha.2) Patients having wound with depth less than 1cm.3) Patients irrespective of sex, religion, occupation etc4) Dimension of wound up to 30sq.cm.5)Patients either Age between 18 to 60 years.6)Patients having wounds on extremities only

Exclusion criteria

Exclusion criteria: 1)Wounds which are dushta.2)Patients having bleeding disorder3) Wounds of size more than 30sq.cm.4) known case of AIDS, DM, Hepatitis B., TB and immunocompromised people5) Patient having wound with depth more than 1cm.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Vranaropankar Churna in the treatment of shuddha vrana after 15daysTimepoint: 15 days study with alternate day dressing and follow up and wound assessment will be done on 0th,5th,10th and 15th day.

Secondary

MeasureTime frame
To study the ropan effect of vranaropankar churna after 15 days of of interventionTimepoint: 15 days study with alternate day dressing & wound assessment will be done on 0th,5th,10th & 15th day

Countries

India

Contacts

Public ContactUmesh Abhiman Paikrao

MES Ayurveda Mahavidyalaya

dr.ashok2575@yahoo.com9422032696

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026